Multiple Sclerosis Therapeutics Market Scope And Analysis

Report Code : TIPRE00004057
Category : Life Sciences

Status : Published
No. of Pages : 169

Buy Now

Multiple Sclerosis Therapeutics Market Analysis, Scope, and Growth by 2027

Buy Now

Multiple Sclerosis Therapeutics Market Report Scope

Report Attribute	Details
Market size in 2019	US$ 24.03 Billion
Market Size by 2027	US$ 39.22 Billion
Global CAGR (2019 - 2027)	6.5%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Drug Class Immunosuppressant and Immunomodulators By Route of Administration Injectable and Oral By Distribution Channel Hospital Pharmacies Retail Pharmacies E-Commerce
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Merck Co Inc Novartis AG Bayer AG Sanofi Bristol Myers Squibb Company Horizon Therapeutics plc TEVA PHARMACEUTICAL INDUSTRIES LTD Takeda Pharmaceutical Company Limited F HOFFMANN LA ROCHE LTD

By Drug Class

Immunosuppressant
Immunomodulators

By Route of Administration

Injectable
Oral

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
E-Commerce

By Geography

North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
South America (SAM)
- Brazil
- Argentina
- Rest of South America

Company Profiles

Merck & Co., Inc.
Novartis AG
Bayer AG
Sanofi
Bristol-Myers Squibb Company
Horizon Therapeutics plc.
TEVA PHARMACEUTICAL INDUSTRIES LTD
Takeda Pharmaceutical Company Limited
F. HOFFMANN-LA ROCHE LTD.
Biogen